Susan Gilmour
Dr. Gilmour is a graduate of the University of Saskatchewan and pursued post-graduate training at The Hospital for Sick Children, Toronto.
Dr. Gilmour is a graduate of the University of Saskatchewan and pursued post-graduate training at The Hospital for Sick Children, Toronto.
I am a pediatric surgeon trained in transplantationand have directed the liver transplant program at the Ann & Robert H. Lurie Children's Hospital since its inception. I have a special interest in disorders of the liver in children including abnormalities of portal circulation, biliary atresia and pediatric liver tumors.
I am a board certified pediatric gastroenterologist and transplant hepatologist, and current an Assistant Professor at the University of Chicago in the section of Pediatric Gastroenterology, Hepatology, and Nutrition. My clinical interests include MASLD and obesity, autoimmune liver diseases, cystic fibrosis associated liver disease, and biliary atresia. My research interests include understanding and addressing psychosocial aspects of hepatology and pediatric liver transplantation.
Janis Stoll, M.D., is the Medical Director of the Pediatric Liver Transplant program and the Healthy Start Clinic at St. Louis Children's Hospital and Washington University School of Medicine. Under her leadership since 2020, the transplant program continues to expand while advancing clinical capabilities to include living donation, combined heart-liver transplantation, and ABO-incompatible liver transplantation for a complex patient population of over 170 transplant patients. Passionate about quality improvement, Dr.
Dr. Sumera I. Ilyas is an Associate Professor of Medicine at Mayo Clinic in Rochester MN. She is a physician-scientist with an academic focus in hepatobiliary neoplasia. She is the director of the Mayo Clinic Hepatobiliary Neoplasia Clinic and Transplant Oncology Clinic. She has a discovery science program focused on the immunobiology of cholangiocarcinoma and development of combination immune-directed therapies for the treatment of cholangiocarcinoma.
JORDAN J FELD MD MPH
Professor of Medicine, University of Toronto, Ontario, Canada
Director of Hepatology, Toronto Centre for Liver Disease, University Health Network
I am a Professor of Medicine in the Division of Digestive Health and Liver Diseases and is the Associate Director of the Schiff Center for Liver Diseases at the University of Miami.
My clinical research program focuses on understanding the natural history, managing symptoms, and designing and implementing clinical trials for autoimmune and cholestatic liver diseases, as well as the porphyrias. I also serve as chair for the AASLD practice guidelines committee and as a steering committee member for the Cholestatic and Autoimmune Liver Diseases SIG in AASLD.
Gregory J. Gores, M.D. is a senior physician scientist. His research contributions include sustained federal funding over three decades (over 80 projects and 21 million in funding), over 750 publications, an H-index of 158 with over 83,000 citations (Scopus data base). His clinical focus on hepatobiliary neoplasia has led to novel protocols regarding liver transplantation for cholangiocarcinoma. Educational activities include mentoring over 81 fellows, and directing a liver transplant fellowship program.
Alexandria, VA – June 5, 2026 – The American Association for the Study of Liver Diseases (AASLD) proudly announces the 2026...
Every year at The Liver Meeting®, AASLD recognizes deserving colleagues for their accomplishments and contributions to the liver community through our Distinguished Awards. These are AASLD’s most prestigious awards.
Congratulations to the 2026 Distinguished Award Recipients!